As of Nov 25
| +1.08 / +2.63%|
The 11 analysts offering 12-month price forecasts for Seattle Genetics Inc have a median target of 45.00, with a high estimate of 65.00 and a low estimate of 33.00. The median estimate represents a +6.61% increase from the last price of 42.21.
The current consensus among 14 polled investment analysts is to Hold stock in Seattle Genetics Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.